Medicinal attributes of pyridine scaffold as anticancer targeting agents

被引：59
|
作者：
Mohamed, Esraa Ali [1 ]
Ismail, Nasser S. M. [2 ]
Hagras, Mohamed [3 ]
Refaat, Hanan [1 ]
机构：
[1] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut Chem, Cairo, Egypt
[2] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
[3] Al Azhar Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
来源：
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES | 2021年 / 7卷 / 01期
关键词：
Pyridines; Anticancer; Cytotoxic action; Tyrosine kinases; NF-KAPPA-B; BIOLOGICAL EVALUATION; DERIVATIVES; DESIGN; CANCER; ANGIOGENESIS; INHIBITORS; CDK9; EGFR;
D O I：
10.1186/s43094-020-00165-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: The heterocyclic compounds particularly pyridine displayed clinical and biological implementation. Pyridine scaffolds have been detected in most relevant drug molecules that included pyridine provided a great possibility for treatment. Main text: Pyridine-containing compounds have increasing importance for medicinal application as antiviral, anticholinesterase activities, antimalarial, antimicrobial, antidiabetic and anticancer. This has generated concern among researchers in synthesising a variety of pyridine derivatives. Conclusion: This review focuses on different pyridine targets as anticancer and their pharmacophoric elements controlling its activity.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Medicinal attributes of pyridine scaffold as anticancer targeting agents
    Esraa Ali Mohamed
    Nasser S. M. Ismail
    Mohamed Hagras
    Hanan Refaat
    Future Journal of Pharmaceutical Sciences, 7
  • [2] Insights into medicinal attributes of imidazo[1,2-a]pyridine derivatives as anticancer agents
    Kumar, Ankush
    Sharma, Vishakha
    Behl, Tapan
    Ganesan, Subbulakshmi
    Nathiya, Deepak
    Gulati, Monica
    Khalid, Mohammad
    Elossaily, Gehan M.
    Chigurupati, Sridevi
    Sachdeva, Monika
    ARCHIV DER PHARMAZIE, 2024, 357 (11)
  • [3] The Syntheses and Medicinal Attributes of Phenanthrenes as Anticancer Agents: A Quinquennial Update
    Jhingran, Sarthak
    Laxmikeshav, Kritika
    Mone, Sayali
    Rao, Venkata K.
    Shankaraiah, Nagula
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (20) : 3530 - 3556
  • [4] Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities
    Ghith, Amna
    Ismail, Nasser S. M.
    Youssef, Khairia
    Abouzid, Khaled A. M.
    ARCHIV DER PHARMAZIE, 2017, 350 (11)
  • [5] Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
    Ismail, Nasser S. M.
    Ali, Ghada M. E.
    Ibrahim, Diaa A.
    Elmetwali, Amira M.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 2 (02) : 60 - 70
  • [6] Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review
    Liu, Zi-Qiang
    Zhang, Qian
    Liu, Yu-Lin
    Chui, Rui-Hao
    Zhang, Lin-Lin
    Zhao, Bing
    Ma, Li-Ying
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 111
  • [7] Medicinal Chemistry of Quinazolines as Anticancer Agents Targeting Tyrosine Kinases
    Zayed, Mohamed F. F.
    SCIENTIA PHARMACEUTICA, 2023, 91 (02)
  • [8] Anticancer agents incorporating the N-acylhydrazone scaffold: Progress from 2017 to present
    Kassab, Asmaa E.
    ARCHIV DER PHARMAZIE, 2023, 356 (05)
  • [9] Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents
    Deep, Aakash
    Bhatia, Richa Kaur
    Kaur, Ramanjot
    Kumar, Sanjiv
    Jain, Upendra Kumar
    Singh, Harinder
    Batra, Sandeep
    Kaushik, Dinesh
    Deb, Pran Kishore
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (02) : 238 - 250
  • [10] New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies
    Srour, Aladdin M.
    Nossier, Eman S.
    Altwaijry, Najla A.
    Mousa, Safeya M.
    Awad, Hanem M.
    Elzahabi, Heba S. A.
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (24) : 2567 - 2582
12345